Skip to main content

GuidelinesRegulatory updates2026.11.13

PPWR Medical Device Packaging Exemptions — A Review Table Separating the Sterile Pouch, Sales Box and Transport Box by Provision

Being a medical device does not take the whole of its packaging out of PPWR. The exemptions sit separately in recyclability (Article 6), recycled content (Article 7), labeling (Article 12) and conformity assessment and technical documentation (Article 15), each with its own packaging in scope and conditions. This guide sets out the definition of contact-sensitive packaging, the exemption conditions by provision, a review table by packaging layer and the common misunderstandings, on the basis of the EU legal text and the Commission guidance.

Key takeaway — The PPWR exemptions for medical device packaging are scattered across four places, not one. Recyclability is in Article 6(11), recycled content in Article 7(4), labeling in Article 12(11), and conformity assessment and technical documentation in Article 15(11). The four exemptions differ in the packaging covered and the conditions, so divide the packaging into layers and then check each provision separately. Do not carry an exemption confirmed for the sterile pouch over to the sales box or the transport box.

This article is based on the EU Packaging and Packaging Waste Regulation, Regulation (EU) 2025/40 (PPWR), as checked on 6 October 2026, and Commission Notice C/2026/3084 (implementation guidance). For the overall scope and preparation documents, see the PPWR preparation guide first; this article covers only the exemptions attached to medical device packaging.

The premise to confirm first: is the item ‘packaging’ under PPWR?

Before looking for exemptions, settle whether the item under review is packaging. Article 3(1)(1) defines packaging as an item, whatever the material, intended to be used by an economic operator to contain, protect, handle, deliver or present products, and includes items that are not an integral part of the product and are used, consumed or disposed of together with the product.

Section 1 of the Commission guidance explains that IV bags and syringes, including when pre-filled, do not fall within the definition of packaging, because they are integrated delivery devices designed, manufactured and regulated for safe and accurate administration to the patient. So a pre-filled syringe itself is not packaging, while the blister or box containing it is judged again against the definition of packaging.

Once judged to be packaging, divide it into layers. Article 3 distinguishes sales packaging (point 5), grouped packaging (point 6) and transport packaging (point 7), and defines e-commerce packaging (point 8) as a kind of transport packaging. The sterile pouch, the sales box holding the device, the grouped packaging bundling several boxes, and the outbound corrugated box with its cushioning are each a different layer.

The test: contact-sensitive packaging is defined by product legislation, not by contact

The medical device exemptions in Articles 6 and 7 both cover ‘contact-sensitive packaging’. Article 3(1)(49) defines this as packaging intended to be used for products within the scope of the listed legislation, including Regulation (EU) 2017/745 (medical devices) and Regulation (EU) 2017/746 (in vitro diagnostic medical devices). Legislation on food contact materials, cosmetics, medicinal products and feed is on the same list.

Three points follow from this definition.

  • The criteria are which legislation the product falls under and whether the packaging is intended to be used for that product. Whether the packaging physically touches the product is not in the wording of the definition.
  • The definition does not distinguish packaging layers. The legal text does not say whether only the pouch qualifies or the transport box too, and the Commission guidance does not address the point. This is a place where the company must record its own basis.
  • Article 6(11) does not limit the material of contact-sensitive packaging, but Article 7(4) applies only to contact-sensitive plastic packaging. A paper box is not within the scope of the Article 7 plastic recycled content requirement in the first place.

Exemption review table by provision

The table below transposes the four exemptions in the legal text into the order in which a packaging officer reads them. The ‘obligation not applied’ column is the scope of the exemption; the other provisions apply as they stand.

Provision Obligation not applied Packaging covered (legal text) Conditions to note when reading
Article 6(11)(b) and (c) The whole of Article 6 (recyclability) Contact-sensitive packaging of medical devices under Regulation (EU) 2017/745 · contact-sensitive packaging of in vitro diagnostic medical devices under Regulation (EU) 2017/746 No material restriction. Point (d) of the same paragraph limits the outer packaging of medicinal products to cases where it is needed to preserve quality, so do not read it together with the medical device points.
Article 7(4)(b) and (c) Article 7(1) and (2) (minimum recycled content in plastic) Contact-sensitive plastic packaging of medical devices, devices for research use only and investigational devices (under 2017/745) · contact-sensitive plastic packaging of in vitro diagnostic medical devices (under 2017/746) Applies only to the plastic part. Article 7(5) provides separate exceptions, such as plastic parts below 5% of the total weight of the packaging unit, so check them together.
Article 12(11) Article 12 (packaging labeling) Immediate packaging and outer packaging as defined in 2017/745, 2017/746, 2019/6 and 2001/83/EC Conditional. Applies only where there is no space on the packaging because of labeling requirements under other EU legislation, or where labeling could endanger the safe use of human or veterinary medicinal products. The medical device regulations have no definition of immediate and outer packaging, so Section 13 of the guidance supplements how to read it (see below).
Article 15(11) Article 15(2) and (3) (carrying out the conformity assessment procedure, drawing up the Annex VII technical documentation, the EU declaration of conformity, 5-year and 10-year retention) Custom-made transport packaging for configurable medical devices and medical systems intended for use in industrial and healthcare environments The other paragraphs of Article 15 (paragraph (1) placing only compliant packaging on the market, paragraph (4) reassessment on changes, paragraphs (5) and (6) identification and manufacturer marking, etc.) apply as they stand. An ordinary shipping box does not fall within this wording.

When applying Article 12(11) to medical devices, Section 13 of the Commission guidance explains that immediate packaging is to be understood as the packaging in contact with the device and outer packaging as the sales packaging of the device. The same section explains that because the sorting label under Article 12(1) is intended to help consumers sort, it does not apply to the packaging of medical devices and in vitro diagnostic medical devices that can be used only by professional end users in industrial and professional activities. This is, however, an explanation of the labeling provision and is not carried over as an exemption from other provisions.

Review table by packaging layer: fictional example

The following is a fictional example for illustration. Suppose a single-use medical device is shipped to an EU importer in a sterile pouch, a paper sales box and a corrugated transport box. Each cell is a question for the person in charge to answer, not a compliance judgment on a specific product.

Packaging layer Is packaging Contact-sensitive packaging Article 6(11) Article 7(4) Article 12(11) Article 15(11) Remaining checks
Sterile pouch Yes Intended for use with a product under the medical device regulation Exemption can be reviewed Exemption can be reviewed for the plastic part only Immediate packaging. Confirm the no-space or safe-use condition Not applicable (not transport packaging) Article 15 identification and manufacturer marking, evidence of sterility maintenance
Paper sales box Yes Review under the same definition, recording the basis Exemption can be reviewed once the basis is written Not plastic (not within Article 7) Outer packaging (sales packaging). Confirm the conditions Not applicable Whether for professional users, technical documentation
Corrugated transport box Yes The legal text does not cut by layer. No exemption marking without a basis Undetermined. Record, then confirm Not plastic Article 12(1) does not apply to transport packaging other than e-commerce packaging Whether custom-made transport packaging for configurable devices or medical systems Evidence of transport protection, technical documentation

The order for filling in the table is as follows.

  1. Divide the packaging into layers on a physical basis and write the function of each layer (sterility maintenance, protection, transport) in one line.
  2. For each layer, record whether it meets the definition of packaging and whether it is contact-sensitive packaging, with the basis.
  3. Fill in the exemption cells for the four provisions one by one, and pass provisions without an exemption to the general rules.
  4. Leave ‘remaining checks’ even in cells where an exemption is confirmed, because an exemption reaches only that provision.
  5. Record in the technical documentation the basis on which the exemption was applied and the date checked.

PPWR medical device packaging exemption matrix — three layers (sterile pouch, sales box, transport box) against four provisions (Article 6(11), Article 7(4), Article 12(11), Article 15(11)) as exemption review cells

Application dates to check separately from the exemptions

Exemption review and application date review are different axes. Under Article 71, PPWR applies from 12 August 2026. The application dates of the detailed requirements differ, however.

Requirement Application date (legal text) How to read it now
Article 6(1) recyclability principle No separate date. Section 6 of the guidance explains that it applies from 12 August 2026 Layers that are not contact-sensitive packaging are currently in scope.
Article 6(2)(a) design-for-recycling criteria 1 January 2030 or 24 months after the Article 6(4) delegated act enters into force, whichever is later Section 6 of the guidance explains that until the delegated act enters into force there is no need to carry out the conformity assessment under Article 38 and Annex VII for recyclability.
Article 7(1) minimum recycled content 1 January 2030 or 3 years after the Article 7(8) implementing act enters into force, whichever is later Not yet applicable, regardless of whether contact-sensitive plastic packaging is exempt.
Article 12(1) harmonized material label 12 August 2028 or 24 months after the relevant implementing act enters into force, whichever is later Transport packaging other than e-commerce packaging is excluded by the legal text.

Common misunderstandings

Common explanation What the legal text provides What the person in charge checks
Medical devices are exempt from PPWR There are only exemptions by provision. No wording excludes the packaging as a whole. Review table by layer and provision
The sterile pouch is exempt, so the box is exempt too The contact-sensitive packaging definition does not distinguish layers, and the guidance does not address it. Record the basis for applying the same exemption to the box
Transport boxes all drop out under Article 15(11) It is an exemption from paragraphs (2) and (3) for custom-made transport packaging for configurable medical devices and medical systems. Whether custom-made, the system covered, the use environment
Article 12(11) applies automatically to medical devices It is an exemption conditioned on lack of space or the safe use of medicinal products. Whether there is no space because of markings under other EU legislation
With the Article 12 exemption, no manufacturer marking is needed either The identification and manufacturer marking under Article 15(5) and (6) are separate provisions. Marking items on the packaging or in an accompanying document
With the recycled content exemption, recyclability is exempt too Article 6(11) and Article 7(4) differ in subject and conditions. A review table with each provision filled in separately

Tie packaging changes to the medical device review

Article 15(4) requires the manufacturer to take account of changes in packaging design or characteristics and to reassess under the Article 38 conformity assessment procedure where compliance may be affected. Changing the pouch material or sealing conditions for the sake of PPWR first unsettles the medical device side's verification of sterility maintenance and transport protection. When reviewing a packaging change, manage it in the same change record as the package testing and sealing process validation covered in sterile packaging validation.

Documents that speed up the review if prepared before inquiring

  • The EU regulation the product falls under (2017/745 or 2017/746) and the user (professional or home use)
  • Photographs of each packaging layer and a one-line description of each layer's function
  • Specifications showing the material of each layer and the proportion of plastic parts
  • Current packaging artwork and the marking items required under other EU legislation
  • List of documents held on sterility and transport protection

Please mention PPWR packaging in your message when you use the PPWR packaging review inquiry. Based on the documents above, we will distinguish the cells where an exemption may apply from those needing further evidence. The scope and cost of the review are advised individually after we have confirmed the packaging configuration and the state of the documents.

Prepared and sources checked: 2026-10-06. Sources: Regulation (EU) 2025/40 Article 3(1)(1), (5) to (8) and (49), Article 6(2) and (11), Article 7(1), (4) and (5), Article 12(1) and (11), Article 15(2) to (7) and (11), Article 38, Article 71 · Commission Notice C/2026/3084 Section 1 (definition of packaging), Section 6 (timing of recyclability application), Section 7 (recycled content exceptions), Section 13 (scope of labeling and Article 12(11)). The guidance is interpretative material and does not replace the legal text. The review table and fictional example are our own practical tools and do not replace a compliance judgment on individual packaging.

Frequently asked questions

Q. Are medical devices excluded from the scope of PPWR?
No. The legal text does not exclude medical devices as a whole. It sets the subject and conditions separately for each provision: the Article 6 and 7 exemptions for contact-sensitive packaging, the conditional Article 12 labeling exemption, and the Article 15(2) and (3) exemption for certain custom-made transport packaging. Provisions without an exemption must be reviewed under the general rules.
Q. If the sterile pouch is contact-sensitive packaging, does the transport box get the same exemption?
The legal text does not say so. Contact-sensitive packaging is defined only as packaging intended to be used for products within the scope of the listed legislation, including the medical device regulations; the scope is not cut by packaging layer or by physical contact. The Commission guidance does not address this point separately either, so to apply the same exemption to the transport box, record the basis in the technical documentation and, if necessary, confirm with the EU importer or the competent authority.
Q. If the Article 12 labeling exemption applies, can the manufacturer's name and address marking be omitted too?
Article 12(11) is an exemption from the labeling under Article 12. The packaging identification information and the manufacturer's name and address marking are set separately in Article 15(5) and (6), so they must be checked separately. Do not treat the two provisions as one exemption.
Q. Are pre-filled syringes or IV bags packaging?
The Commission guidance explains that IV bags and syringes, including when pre-filled, do not fall within the definition of packaging in Article 3, because they are regarded as integrated delivery devices for administration to the patient. However, the pouch or box containing that device is judged again against the definition of packaging.

Just send the product details.
We do the reviewing.

We pre-review device class, required pathway, and data readiness free of charge, and reply within 1 business day. No sign-up.